Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment of major depressive disorder (MDD) and diabetic ...
de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
“The condition is commonly associated with the use of certain medications, particularly those that enhance serotonin activity, such as selective serotonin reuptake inhibitors (SSRIs), ...
In patients receiving serotonergic medications in combination with an MAOI, there have been reports of serious and sometimes fatal reactions, including hyperthermia, rigidity, myoclonus, autonomic ...
We deliver climate news to your inbox like nobody else. Every day or once a week, our original stories and digest of the web's top headlines deliver the full story, for free. ICN provides award ...
Before 2018, the last major advancement in mental healthcare was the 1988 introduction of fluoxetine, the first selective serotonin reuptake inhibitor (SSRI). Selective norepinephrine reuptake ...
We deliver climate news to your inbox like nobody else. Every day or once a week, our original stories and digest of the web's top headlines deliver the full story, for free. ICN provides award ...